1. Home
  2. SCLX vs MDCX Comparison

SCLX vs MDCX Comparison

Compare SCLX & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$0.57

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

HOLD

Current Price

$1.14

Market Cap

10.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
MDCX
Founded
2011
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
10.9M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
SCLX
MDCX
Price
$0.57
$1.14
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $32.50
AVG Volume (30 Days)
★ 73.1K
54.5K
Earning Date
12-01-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $30,253,000.00
N/A
Revenue This Year
$118.16
N/A
Revenue Next Year
$186.31
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.54
$1.15
52 Week High
$23.03
$114.00

Technical Indicators

Market Signals
Indicator
SCLX
MDCX
Relative Strength Index (RSI) 8.42 21.39
Support Level N/A N/A
Resistance Level $7.77 $2.16
Average True Range (ATR) 0.17 0.26
MACD -0.04 0.15
Stochastic Oscillator 2.80 11.77

Price Performance

Historical Comparison
SCLX
MDCX

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

Share on Social Networks: